CASC
UBS Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-295
| Closed | -$1K | – | 7311 |
|
|
2017
Q4 | $1K | Sell |
295
-1,475
| -83% | -$5K | ﹤0.01% | 6807 |
|
|
2017
Q3 | $7K | Buy |
1,770
+918
| +108% | +$3.63K | ﹤0.01% | 6197 |
|
|
2017
Q2 | $3K | Sell |
852
-11,970
| -93% | -$42.1K | ﹤0.01% | 6386 |
|
|
2017
Q1 | $53K | Buy |
12,822
+12,576
| +5,112% | +$52K | ﹤0.01% | 4596 |
|
|
2016
Q4 | $1K | Sell |
246
-43,054
| -99% | -$175K | ﹤0.01% | 6695 |
|
|
2016
Q3 | $71K | Buy |
+43,300
| New | +$71K | ﹤0.01% | 4380 |
|
|
2016
Q2 | – | Sell |
-7,984
| Closed | -$10K | – | 7075 |
|
|
2016
Q1 | $10K | Buy |
+7,984
| New | +$10K | ﹤0.01% | 5834 |
|
|
2015
Q3 | – | Sell |
-16,708
| Closed | -$62K | – | 7080 |
|
|
2015
Q2 | $62K | Buy |
16,708
+15,809
| +1,759% | +$58.7K | ﹤0.01% | 4636 |
|
|
2015
Q1 | $1K | Sell |
899
-16,547
| -95% | -$18.4K | ﹤0.01% | 6575 |
|
|
2014
Q4 | $33K | Buy |
+17,446
| New | +$33K | ﹤0.01% | 5089 |
|